In today’s one-on-one interview from Rheumatology Network, we feature a discussion with Jagadeesh Bayry, Ph.D., and Caroline Galeotti, M.D., of the University of Paris who recently described in Nature Reviews Rheumatology, pediatric cases of COVID-19 that were associated with the development of pediatric inflammatory multisystemic syndrome, or, PIMS in children. Children who developed PIMS exhibited signs of the vasculitis syndrome Kawasaki disease without having the disease itself. The condition eventually resolved in most of their patients. And, while the pandemic is under control in Paris, cases are still rising in most U.S. cities that may begin to see vasculitis symptoms in children described in this report.